Hypertension, Systemic Inflammation and Body Weight in Relation to Lung Function Impairment—An Epidemiological Study
Authors:
- Olof Birna MargretardottirOMOlof Birna Margretardottir
- Sigurdur James ThorleifssonSTSigurdur James Thorleifsson
- Gunnar GudmundssonGGGunnar Gudmundsson
- Isleifur OlafssonIOIsleifur Olafsson
- Bryndis BenediktsdottirBBBryndis Benediktsdottir
- Christer JansonCJChrister Janson
- A. Sonia BuistABA. Sonia Buist
- Thorarinn GislasonTGThorarinn Gislason
- 1 January 2009
- journal article
- Published by Taylor & Francis in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 6 (4) , 250-255
Abstract
Recent reports on the simultaneous occurrence of systemic inflammation and airflow obstruction are usually based on a highly selective patient population, but their importance warrants further evaluation in the general population. The objectives were to study the interrelationship between airflow obstruction, smoking, hypertension, obesity and CRP as a marker of systemic inflammation in a randomly selected sample of the general Icelandic population (n = 939). This study comprised 758 randomly selected men and women 40 years and older living in Reykjavik, Iceland, and who were participating in the Burden of Obstructive Lung Disease (BOLD) study (81% response rate). In addition to the BOLD protocol, which included post-bronchodilator spirometry, they answered questions about general health and medication. Serum samples were taken for measurement of C-reactive protein (CRP). In the sample-245 individuals (33%) reported having hypertension. Subjects with hypertension were older, had a higher BMI and higher CRP levels. Subjects with hypertension had lower values of FEV(1) than predicted (89.9 +/- 18.5 vs. 94.5 +/- 14.4%) (p < 0.001) and FVC (92.2 +/- 15.1 vs. 95.3 +/- 12.3%) (p = 0.002). These differences remained significant after adjusting for age, BMI, CRP and smoking. Hypertension and CRP levels above the median were both independently and additively associated with lower FEV(1) and FVC. In addition a lower FVC% was also associated with a higher BMI (> 30 mg/m2). Use of betablocking antihypertensives was not related to lung function. Hypertension, BMI and systemic inflammation affect lung function independently of each other. All three variables have a negative effect on FVC, while hypertension and high CRP were independently associated with impaired FEV(1).Keywords
This publication has 29 references indexed in Scilit:
- Osteoporosis in chronic obstructive pulmonary disease patientsCurrent Opinion in Pulmonary Medicine, 2008
- Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitationThorax, 2008
- From COPD to chronic systemic inflammatory syndrome?The Lancet, 2007
- Global burden of COPD: risk factors, prevalence, and future trendsThe Lancet, 2007
- International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyThe Lancet, 2007
- Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine DysregulationDiabetes, 2007
- Mortality in COPD: role of comorbiditiesEuropean Respiratory Journal, 2006
- Raised CRP levels mark metabolic and functional impairment in advanced COPDThorax, 2005
- C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological studyThorax, 2005
- Respiratory Function and Risk of StrokeStroke, 1995